Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS. Dimopoulos MA, et al. Among authors: fernandez de larrea c. J Clin Oncol. 2023 Nov 20;41(33):5099-5106. doi: 10.1200/JCO.22.02830. Epub 2023 Jul 21. J Clin Oncol. 2023. PMID: 37478390 Clinical Trial.
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, García-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyż J, Fernández De Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Wu B, Yu Y, Shen Z, Chan WY, Schneider J, Allewelt H, Cohen A, Dimopoulos MA. Tam CS, et al. Among authors: fernandez de larrea c. Blood Adv. 2024 Apr 9;8(7):1639-1650. doi: 10.1182/bloodadvances.2023010906. Blood Adv. 2024. PMID: 38315878 Free PMC article.
Multiple myeloma.
Bladé J, Cibeira MT, Fernández de Larrea C, Rosiñol L. Bladé J, et al. Among authors: fernandez de larrea c. Ann Oncol. 2010 Oct;21 Suppl 7:vii313-9. doi: 10.1093/annonc/mdq363. Ann Oncol. 2010. PMID: 20943635 Free article. Review.
Response evaluation and monitoring of multiple myeloma.
Fernández de Larrea C, Delforge M, Davies F, Bladé J. Fernández de Larrea C, et al. Expert Rev Hematol. 2014 Feb;7(1):33-42. doi: 10.1586/17474086.2014.876899. Expert Rev Hematol. 2014. PMID: 24483347 Review.
Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking.
Martin-Antonio B, Najjar A, Robinson SN, Chew C, Li S, Yvon E, Thomas MW, Mc Niece I, Orlowski R, Muñoz-Pinedo C, Bueno C, Menendez P, Fernández de Larrea C, Urbano-Ispizua A, Shpall EJ, Shah N. Martin-Antonio B, et al. Among authors: fernandez de larrea c. Cell Death Differ. 2015 Jan;22(1):96-107. doi: 10.1038/cdd.2014.120. Epub 2014 Aug 29. Cell Death Differ. 2015. PMID: 25168239 Free PMC article.
Allogeneic hematopoietic SCT in multiple myeloma: long-term results from a single institution.
Rosiñol L, Jiménez R, Rovira M, Martínez C, Fernández-Avilés F, Marín P, Suárez-Lledó M, Gutiérrez-García G, Fernández de Larrea C, Carreras E, Urbano-Ispizua A, Bladé J. Rosiñol L, et al. Among authors: fernandez de larrea c, fernandez aviles f. Bone Marrow Transplant. 2015 May;50(5):658-62. doi: 10.1038/bmt.2014.320. Epub 2015 Jan 26. Bone Marrow Transplant. 2015. PMID: 25621810
93 results